Design of New Bis-triazolyl Structure for Identification of Inhibitory Activity on COVID-19 Main Protease by Molecular Docking Approach

Overview

Journal J Mol Struct

Publisher Elsevier

Specialty Chemistry

Date 2021 Nov 8

PMID 34744185

Citations 3

Authors

Gurjaspreet Singh

Pawan

Mohit

Diksha

Suman

Priyanka

Sushma

Anamika Saini

Amarjit Kaur

Affiliations

Soon will be listed here.

Abstract

In the rapidly growing COVID-19 pandemic, designing of new drugs and evaluating their inhibitory action against main targets of corona virus could be an effective strategy to accelerate the drug discovery process and their efficacy towards corona virus disease. Herein, we design new bis-triazolyl probe for an investigation of inhibitory activity towards COVID-19 main protease by Molecular docking approach. The formulated compound has been thoroughly characterized by elemental analysis, NMR (H and C) and complete structure elucidation was achieved via X-ray crystallography. Docking study reveals that newly synthesized compound confers good inhibitory response to COVID-19 main protease as supported by calculated docking score and binding energy. Strong hydrogen bonding and hydrophobic interactions of the newly synthesized compound with several important amino acids of the main protease also helps to explain the potency of the compound to inhibit the main protease. We hope that the present study would help the researcher in the field of Medicinal chemistry and to develop potential drug against the novel corona virus.

Citing Articles

A Comprehensive Update of Anti-COVID-19 Activity of Heterocyclic Compounds.

Nazir M, Ahmad M, Aslam S, Rafiq A, Al-Hussain S, Zaki M Drug Des Devel Ther. 2024; 18:1547-1571.

PMID: 38737333 PMC: 11088867. DOI: 10.2147/DDDT.S450499.

Synthesis, crystal structure and studies of novel 2,4-dimethoxy-tetrahydropyrimido[4,5-]quinolin-6(7)-ones.

Patel S, Vala R, Patel P, Upadhyay D, Ramkumar V, Gardas R RSC Adv. 2022; 12(29):18806-18820.

PMID: 35873341 PMC: 9240959. DOI: 10.1039/d2ra02694e.

Synthesis and characterization of two new mixed-ligand Cu(II) complexes of a tridentate NN'O type Schiff base ligand and N-donor heterocyclic co-ligands: In vitro anticancer assay, DNA/human leukemia/COVID-19 molecular docking studies, and....

Ghasemi L, Behzad M, Khaleghian A, Abbasi A, Abedi A Appl Organomet Chem. 2022; 36(5):e6639.

PMID: 35538931 PMC: 9073997. DOI: 10.1002/aoc.6639.

References

Peterson L, Blagg B . Click chemistry to probe Hsp90: Synthesis and evaluation of a series of triazole-containing novobiocin analogues. Bioorg Med Chem Lett. 2010; 20(13):3957-60. PMC: 2924929. DOI: 10.1016/j.bmcl.2010.04.140. View

Doiron J, Soultan A, Richard R, Toure M, Picot N, Richard R . Synthesis and structure-activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors. Eur J Med Chem. 2011; 46(9):4010-24. DOI: 10.1016/j.ejmech.2011.05.074. View

Mochizuki M, Kojima T, Kobayashi K, Kotani E, Ishichi Y, Kanzaki N . Discovery of 4-chloro-2-(2,4-dichloro-6-methylphenoxy)-1-methyl-7-(pentan-3-yl)-1H-benzimidazole, a novel CRF receptor antagonist. Bioorg Med Chem. 2017; 25(5):1556-1570. DOI: 10.1016/j.bmc.2016.11.011. View

Cui W, Yang K, Yang H . Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19. Front Mol Biosci. 2020; 7:616341. PMC: 7746807. DOI: 10.3389/fmolb.2020.616341. View

Singh U, Shankar R, Yadav G, Kharkwal G, Dwivedi A, Keshri G . Synthesis and structure guided evaluation of estrogen agonist and antagonist activities of some new tetrazolyl indole derivatives. Eur J Med Chem. 2007; 43(10):2149-58. DOI: 10.1016/j.ejmech.2007.10.035. View

Morris G, Huey R, Lindstrom W, Sanner M, Belew R, Goodsell D . AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009; 30(16):2785-91. PMC: 2760638. DOI: 10.1002/jcc.21256. View

Baumann M, Baxendale I . An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles. Beilstein J Org Chem. 2013; 9:2265-319. PMC: 3817479. DOI: 10.3762/bjoc.9.265. View

Sohrabi C, Alsafi Z, ONeill N, Khan M, Kerwan A, Al-Jabir A . World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020; 76:71-76. PMC: 7105032. DOI: 10.1016/j.ijsu.2020.02.034. View

Sheldrick G . SHELXT - integrated space-group and crystal-structure determination. Acta Crystallogr A Found Adv. 2014; 71(Pt 1):3-8. PMC: 4283466. DOI: 10.1107/S2053273314026370. View

10.

Brik A, Alexandratos J, Lin Y, Elder J, Olson A, Wlodawer A . 1,2,3-triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors. Chembiochem. 2005; 6(7):1167-9. DOI: 10.1002/cbic.200500101. View

11.

Singh U, Shankar R, Kumar A, Trivedi R, Chattopadhyay N, Shakya N . Synthesis and biological evaluation of indolyl bisphosphonates as anti-bone resorptive and anti-leishmanial agents. Bioorg Med Chem. 2008; 16(18):8482-91. DOI: 10.1016/j.bmc.2008.08.024. View

12.

Xue X, Yu H, Yang H, Xue F, Wu Z, Shen W . Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. J Virol. 2007; 82(5):2515-27. PMC: 2258912. DOI: 10.1128/JVI.02114-07. View

13.

Hopkinson M, Richter C, Schedler M, Glorius F . An overview of N-heterocyclic carbenes. Nature. 2014; 510(7506):485-96. DOI: 10.1038/nature13384. View

14.

Zhang H, Yang Y, Steinbrecher U . Structural requirements for the binding of modified proteins to the scavenger receptor of macrophages. J Biol Chem. 1993; 268(8):5535-42. View

15.

Cocklin S, Gopi H, Querido B, Nimmagadda M, Kuriakose S, Cicala C . Broad-spectrum anti-human immunodeficiency virus (HIV) potential of a peptide HIV type 1 entry inhibitor. J Virol. 2007; 81(7):3645-8. PMC: 1866025. DOI: 10.1128/JVI.01778-06. View

16.

Raj R, Singh P, Singh P, Gut J, Rosenthal P, Kumar V . Azide-alkyne cycloaddition en route to 1H-1,2,3-triazole-tethered 7-chloroquinoline-isatin chimeras: synthesis and antimalarial evaluation. Eur J Med Chem. 2013; 62:590-6. DOI: 10.1016/j.ejmech.2013.01.032. View

17.

Shankar R, Chakravarti B, Singh U, Ansari M, Deshpande S, Dwivedi S . Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents. Bioorg Med Chem. 2009; 17(11):3847-56. DOI: 10.1016/j.bmc.2009.04.032. View

18.

Welsch M, Snyder S, Stockwell B . Privileged scaffolds for library design and drug discovery. Curr Opin Chem Biol. 2010; 14(3):347-61. PMC: 2908274. DOI: 10.1016/j.cbpa.2010.02.018. View

19.

Mengist H, Dilnessa T, Jin T . Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease. Front Chem. 2021; 9:622898. PMC: 8056153. DOI: 10.3389/fchem.2021.622898. View

20.

Sheldrick G . Crystal structure refinement with SHELXL. Acta Crystallogr C Struct Chem. 2015; 71(Pt 1):3-8. PMC: 4294323. DOI: 10.1107/S2053229614024218. View